SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased institutional accumulation and positive sentiment driven by DefenCath market adoption and ongoing clinical developments. While shareholders are actively discussing upcoming catalyst timelines and the company's long-term commercial strategy, some investors remain focused on navigating short-term volatility and institutional positioning.

Chip

Chip (USD.AI) is seeing intense community debate as market participants weigh its GPU-backed lending model against concerns regarding token supply, potential insider selling, and volatile price action. While supporters highlight the project's real-world utility in financing AI compute infrastructure, skeptics are actively shorting the asset, pointing to persistent downward pressure and the long-term dilution risks from future token unlocks.

Aeluma, Inc. engages in developing semiconductors for sensing, communication, and computing applications. The firm is also involved in manufacturing devices using compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass market microelectronics. The company was founded by Jonathan Klamkin and Lee McCarthy on February 28, 2019 and is headquartered in Goleta, CA.

Aeluma Inc

Aeluma is trending as investors monitor its role in the critical AI photonics infrastructure, with community discussion focused on its $30 million CHIPS Act funding and strategic partnerships with Tower Semiconductor and Sumitomo Chemical. Traders are closely tracking the company's progress toward commercializing its non-InP semiconductor platform while weighing a significant short interest against management's recent hiring and potential future demand for high-performance optical interconnects.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is gaining significant attention as investors monitor institutional accumulation and the ongoing progress of the Clarity Act, which many believe will provide essential regulatory certainty for cross-border payment utility. Community sentiment remains polarized, with some bulls emphasizing long-term institutional partnerships and tokenization potential, while skeptics point to price stagnation and the challenges of replacing traditional financial infrastructure.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

The Grayscale Bitcoin Mini Trust ETF is trending as investors grapple with significant volatility and institutional capital rotation away from digital assets amid broader concerns over liquidity and macroeconomic shifts. Market participants are actively debating the sustainability of current price support levels while monitoring how institutional positioning and potential regulatory developments continue to influence crypto market structure.

Aventus Network

Aventus Network is seeing significant community attention following a steep price decline, with many investors debating the potential of its enterprise-focused infrastructure amid reported platform accessibility issues. The community is actively discussing the long-term utility of the Aventus Cloud node ecosystem while encouraging others to rotate into the asset.

BitGo Holdings, Inc. operates as a digital asset infrastructure company delivering custody, wallets, staking, trading, financing, stablecoins, and settlement services from regulated cold storage. It focuses on accelerating the transition of the financial system to a digital asset economy. The company was founded by Michael Belshe and Ben Davenport in 2013 and is headquartered in Sioux Falls, SD.

BitGo Holdings Inc. - Ordinary Shares - Class A

BitGo Holdings is trending as investors debate its potential as a long-term infrastructure play for institutional crypto adoption versus short-term price volatility. The community remains divided, with some highlighting the company's role in stablecoin support and strategic partnerships, while others express concerns over speculative sentiment, recent earnings results, and overall market sensitivity.

Select Sector SPDR Trust (The) - State Street Technology Select Sector SPDR ETF

Technology Select Sector SPDR Fund

The technology sector is currently experiencing heightened volatility as investors rotate away from broad, mega-cap indices like XLK in favor of more specialized, memory-focused, and defensive plays. The community is actively debating whether these pullbacks represent a structural breakdown in AI-driven momentum or a healthy accumulation phase amid ongoing earnings and macro uncertainty.

Wix.com Ltd. engages in providing a web development platform for creators, delivering its solutions through a Software-as-a-Service model. Its products include website templates, website builder, website design, Wix features, app market, web hosting, domain names, website accessibility, mobile app builder, and AI website builder. The company was founded by Avishai Abrahami, Nadav Abrahami, Nir Zohar, and Giora Kaplan on October 5, 2006 and is headquartered in Tel Aviv, Israel.

Wix.com Ltd

Wix is trending as investors weigh strong AI-driven growth metrics and product momentum from platforms like Base44 against volatility stemming from share buyback dynamics and broader software sector pressure. The community is actively debating the company's long-term competitive position against AI disruption, with many focused on whether recent management initiatives and aggressive capital allocation will trigger a significant price rebound.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors digest a strong Q2 earnings report that showcased robust revenue growth and profitable results, while the community remains hyper-focused on the potential for a short squeeze and the broader implications of its pipeline programs. Shareholders are actively debating the company's long-term valuation and the likelihood of a strategic acquisition, particularly in light of recent institutional accumulation and the ongoing commercial rollout of its lead therapy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Does Cobenfy Have the Potential to Become a Top Drug for BMY?

BMY's Cobenfy gains traction with $155M in 2025 sales, outpacing peers and showing strong uptake as Bristol Myers eyes new indications and growth.

Why Did RVPH Stock Crash 40% In Pre-Market Today?

Equity

The company priced its $10 million offering at a 20% discount from Wednesday’s close.

Investors Purchase Large Volume of Call Options on Reviva Pharmaceuticals (NASDAQ:RVPH)

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH - Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 25,745 call options on the...

Why Did RVPH Stock Crash 50% Today?

The company announced that the FDA called for an additional Phase 3 trial of its schizophrenia treatment drug.

Reviva Pharmaceuticals (NASDAQ:RVPH) Earns "Buy" Rating from D. Boral Capital

D. Boral Capital reaffirmed a "buy" rating and issued a $2.00 target price on shares of Reviva Pharmaceuticals in a report on Tuesday...

Reviva Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:RVPH)

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH - Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders acquired 27,891 call options on the...

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) Given Average Rating of "Moderate Buy" by Brokerages

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH - Get Free Report) has earned a consensus rating of "Moderate Buy" from the nine brokerages that are currently covering the company, MarketBeat.com...

Brokers Offer Predictions for RVPH FY2025 Earnings

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH - Free Report) - Analysts at Chardan Capital issued their FY2025 earnings per share estimates for Reviva Pharmaceuticals in a research note issued...

Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline expansion potential.

10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.


Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.

Reviva Pharmaceuticals Holdings Inc.

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info

RVPHReviva Pharmaceuticals Holdings Inc.

Fundamentals

Connect Stocktwits to ChatGPT

Latest RVPH News